M&A: Olin and Huntsman agreed to an all-stock merger of equals creating a ~$12B/year chemical player, targeting cost synergies and expanded chlorine optionality, with close expected in Q1 2027. Formulation & Fragrance: Croda commissioned a Guangzhou facility combining Croda Beauty Actives and Iberchem Fragrances to serve Asia with locally relevant botanicals and fragrance tech. Biopharma Manufacturing: Lonza signed multiple ADC licensing deals with US biotechs, supplying payload/linker components under agreements that include upfront and milestone payments. Silicones Expansion: Dow will invest ~$100M by end-2027 to expand speciality silicones for mobility, electronics and medical uses across US, China and Japan. PFAS & Compliance: Chemours faces a $450M “forever chemicals” settlement, adding pressure on PFAS remediation and regulatory scrutiny. Energy Chemicals Supply: India eased LPG supply curbs for industrial/commercial users after Strait of Hormuz reopening, while Crisil warned West Asia tensions could still dent corporate margins. Water Safety: Lebanon County restaurant inspections flagged chemicals stored above food packaging, and PFAS concerns continue to drive water testing and remediation debates.